227 related articles for article (PubMed ID: 22117756)
1. Rapamycin inhibits transforming growth factor β-induced peritoneal angiogenesis by blocking the secondary hypoxic response.
Sekiguchi Y; Zhang J; Patterson S; Liu L; Hamada C; Tomino Y; Margetts PJ
J Cell Mol Med; 2012 Aug; 16(8):1934-45. PubMed ID: 22117756
[TBL] [Abstract][Full Text] [Related]
2. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
[TBL] [Abstract][Full Text] [Related]
3. Gremlin promotes peritoneal membrane injury in an experimental mouse model and is associated with increased solute transport in peritoneal dialysis patients.
Siddique I; Curran SP; Ghayur A; Liu L; Shi W; Hoff CM; Gangji AS; Brimble KS; Margetts PJ
Am J Pathol; 2014 Nov; 184(11):2976-84. PubMed ID: 25194662
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 9 is associated with peritoneal membrane solute transport and induces angiogenesis through β-catenin signaling.
Padwal M; Siddique I; Wu L; Tang K; Boivin F; Liu L; Robertson J; Bridgewater D; West-Mays J; Gangji A; Brimble KS; Margetts PJ
Nephrol Dial Transplant; 2017 Jan; 32(1):50-61. PubMed ID: 27190383
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif.
Land SC; Tee AR
J Biol Chem; 2007 Jul; 282(28):20534-43. PubMed ID: 17502379
[TBL] [Abstract][Full Text] [Related]
6. The role of WNT5A and Ror2 in peritoneal membrane injury.
Padwal M; Liu L; Margetts PJ
J Cell Mol Med; 2020 Mar; 24(6):3481-3491. PubMed ID: 32052562
[TBL] [Abstract][Full Text] [Related]
7. WNT signaling is required for peritoneal membrane angiogenesis.
Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
[TBL] [Abstract][Full Text] [Related]
8. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
9. Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.
Chen YT; Chang YT; Pan SY; Chou YH; Chang FC; Yeh PY; Liu YH; Chiang WC; Chen YM; Wu KD; Tsai TJ; Duffield JS; Lin SL
J Am Soc Nephrol; 2014 Dec; 25(12):2847-58. PubMed ID: 24854266
[TBL] [Abstract][Full Text] [Related]
10. TGF-β/Smad3 activates mammalian target of rapamycin complex-1 to promote collagen production by increasing HIF-1α expression.
Rozen-Zvi B; Hayashida T; Hubchak SC; Hanna C; Platanias LC; Schnaper HW
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F485-94. PubMed ID: 23761672
[TBL] [Abstract][Full Text] [Related]
11. Platelet derived growth factor B and epithelial mesenchymal transition of peritoneal mesothelial cells.
Patel P; West-Mays J; Kolb M; Rodrigues JC; Hoff CM; Margetts PJ
Matrix Biol; 2010 Mar; 29(2):97-106. PubMed ID: 19896531
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β-induced peritoneal fibrosis is mouse strain dependent.
Margetts PJ; Hoff C; Liu L; Korstanje R; Walkin L; Summers A; Herrick S; Brenchley P
Nephrol Dial Transplant; 2013 Aug; 28(8):2015-27. PubMed ID: 22785109
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneum.
Margetts PJ; Kolb M; Yu L; Hoff CM; Holmes CJ; Anthony DC; Gauldie J
Am J Pathol; 2002 Jun; 160(6):2285-94. PubMed ID: 12057931
[TBL] [Abstract][Full Text] [Related]
16. Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of Rho GTPases.
Xiang S; Li M; Xie X; Xie Z; Zhou Q; Tian Y; Lin W; Zhang X; Jiang H; Shou Z; Chen J
FEBS J; 2016 Jun; 283(12):2309-25. PubMed ID: 27093550
[TBL] [Abstract][Full Text] [Related]
17. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis.
Washida N; Wakino S; Tonozuka Y; Homma K; Tokuyama H; Hara Y; Hasegawa K; Minakuchi H; Fujimura K; Hosoya K; Hayashi K; Itoh H
Nephrol Dial Transplant; 2011 Sep; 26(9):2770-9. PubMed ID: 21378147
[TBL] [Abstract][Full Text] [Related]
18. TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model.
Yoshio Y; Miyazaki M; Abe K; Nishino T; Furusu A; Mizuta Y; Harada T; Ozono Y; Koji T; Kohno S
Kidney Int; 2004 Oct; 66(4):1677-85. PubMed ID: 15458466
[TBL] [Abstract][Full Text] [Related]
19. Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis.
Liappas G; González-Mateo G; Aguirre AR; Abensur H; Albar-Vizcaino P; Parra EG; Sandoval P; Ramírez LG; Del Peso G; Acedo JM; Bajo MA; Selgas R; Sánchez Tomero JA; López-Cabrera M; Aguilera A
Oncotarget; 2016 May; 7(21):30133-46. PubMed ID: 27102153
[TBL] [Abstract][Full Text] [Related]
20. Peritoneal morphological and functional changes associated with platelet-derived growth factor B.
Cina D; Patel P; Bethune JC; Thoma J; Rodriguez-Lecompte JC; Hoff CM; Liu L; Margetts PJ
Nephrol Dial Transplant; 2009 Feb; 24(2):448-57. PubMed ID: 18775895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
